GB1262864A - Diazacarbazoles - Google Patents

Diazacarbazoles

Info

Publication number
GB1262864A
GB1262864A GB1532868A GB1532868A GB1262864A GB 1262864 A GB1262864 A GB 1262864A GB 1532868 A GB1532868 A GB 1532868A GB 1532868 A GB1532868 A GB 1532868A GB 1262864 A GB1262864 A GB 1262864A
Authority
GB
United Kingdom
Prior art keywords
march
antiviral
compositions
agent
diazacarbazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1532868A
Inventor
John Derek Cocker
Gordon Ian Gregory
Godfrey Basil Webb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to GB1532868A priority Critical patent/GB1262864A/en
Priority to NL6904815A priority patent/NL6904815A/xx
Priority to IE42969A priority patent/IE33207B1/en
Priority to DE19691916011 priority patent/DE1916011A1/en
Priority to CH475569A priority patent/CH549039A/en
Priority to FR6909437A priority patent/FR2005118A1/fr
Publication of GB1262864A publication Critical patent/GB1262864A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

1,262,864. Antiviral compositions. GLAXO LABORATORIES Ltd. 25 March, 1969 [29 March, 1968], No. 15328/68. Heading A5B. [Also in Division C2] Therapeutic compositions for oral, topical, rectal intravaginal or parenteral administration contain as antiviral agent a 1, 3- or 1, 8-diazacarbazole (or their physiologically acceptable salts), together with a carrier, excipient and/or further medicinal agent; the latter may be a steroid such as betamethasone-21-phosphate or an antibiotic such as tetracycline.
GB1532868A 1968-03-29 1968-03-29 Diazacarbazoles Expired GB1262864A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB1532868A GB1262864A (en) 1968-03-29 1968-03-29 Diazacarbazoles
NL6904815A NL6904815A (en) 1968-03-29 1969-03-28
IE42969A IE33207B1 (en) 1968-03-29 1969-03-28 Diazacarbazoles
DE19691916011 DE1916011A1 (en) 1968-03-29 1969-03-28 Diazacarbazole as an anti-virus agent
CH475569A CH549039A (en) 1968-03-29 1969-03-28 PROCESS FOR THE PREPARATION OF 1,3- AND 1,8-DIAZACARBAZOLES.
FR6909437A FR2005118A1 (en) 1968-03-29 1969-03-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1532868A GB1262864A (en) 1968-03-29 1968-03-29 Diazacarbazoles

Publications (1)

Publication Number Publication Date
GB1262864A true GB1262864A (en) 1972-02-09

Family

ID=10057154

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1532868A Expired GB1262864A (en) 1968-03-29 1968-03-29 Diazacarbazoles

Country Status (6)

Country Link
CH (1) CH549039A (en)
DE (1) DE1916011A1 (en)
FR (1) FR2005118A1 (en)
GB (1) GB1262864A (en)
IE (1) IE33207B1 (en)
NL (1) NL6904815A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110295002A1 (en) * 2007-08-27 2011-12-01 Aleem Gangjee Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
WO2013110198A1 (en) * 2012-01-27 2013-08-01 Université de Montréal Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
CN110156792A (en) * 2019-06-28 2019-08-23 广州暨南生物医药研究开发基地有限公司 A kind of pyrimido benzazolyl compounds and its preparation method and application

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2019812C (en) * 1989-06-28 2000-11-21 Gunther Schmidt (Deceased) Novel 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids
WO2014145576A2 (en) 2013-03-15 2014-09-18 Northwestern University Substituted pyrrolo(2,3-d)pyrimidines for the treatment of cancer

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10414777B2 (en) 2007-08-27 2019-09-17 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and method of use thereof
US11091500B2 (en) 2007-08-27 2021-08-17 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US9056869B2 (en) * 2007-08-27 2015-06-16 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US20110295002A1 (en) * 2007-08-27 2011-12-01 Aleem Gangjee Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US9458167B2 (en) 2007-08-27 2016-10-04 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US9556198B2 (en) 2007-08-27 2017-01-31 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US9802955B2 (en) 2007-08-27 2017-10-31 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US9987283B2 (en) 2007-08-27 2018-06-05 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US10676483B2 (en) 2007-08-27 2020-06-09 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US10464944B2 (en) 2007-08-27 2019-11-05 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US9409906B2 (en) 2012-01-27 2016-08-09 Universite De Montreal Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cells
US10336747B2 (en) 2012-01-27 2019-07-02 Université de Montréal Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cells
WO2013110198A1 (en) * 2012-01-27 2013-08-01 Université de Montréal Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
CN110156792A (en) * 2019-06-28 2019-08-23 广州暨南生物医药研究开发基地有限公司 A kind of pyrimido benzazolyl compounds and its preparation method and application

Also Published As

Publication number Publication date
FR2005118A1 (en) 1969-12-05
IE33207B1 (en) 1974-04-17
CH549039A (en) 1974-05-15
DE1916011A1 (en) 1970-03-05
IE33207L (en) 1969-09-29
NL6904815A (en) 1969-10-01

Similar Documents

Publication Publication Date Title
ES368496A1 (en) Aqueous doxycycline compositions
GB1262864A (en) Diazacarbazoles
GB1268771A (en) Azacarbazoles
GB1202148A (en) Pharmaceutical compositions
CA947766A (en) Dipyrazolo(3,4-b:3',4'-d) pyridin-3-ones
ES368325A1 (en) Cephalosporius having a thioltherified methyl group in the 3-position
GB1358098A (en) Anti-inflammatory preparations containing tetrahydrocarbazole derivatives
GB1268188A (en) N-hydroxyalkyl-2,4,6-triiodosuccinanilic acids and their use as x-ray contrast agents
GB1175590A (en) Therapeutic Compositions
CA858573A (en) Pharmacologically active hexahydroisoquinolino (2, 1-d) benzo (1,4) diazepine compound and salts thereof
AU429842B2 (en) New pharmaceutically active 2, 3 benzoazine derivatives
GB1242742A (en) Drug for stimulating the central nervous system
AU4660768A (en) N, n'disubstituted diazacycloalkanes alkylated at carbon atoms of the heterocyclus and pharmacologically acceptable acid addition salts thereof
GB1318533A (en) 3-2-cyanophenoxy-2-hydroxy-n-ethyl-propylamine
AU4368968A (en) New pharmaceutically active 2, 3 benzoazine derivatives
CA832026A (en) Pharmacologically active secondary aralkylamines and salts thereof
GB1178637A (en) Anthelmintic Compositions
AU430171B2 (en) Pharmacologically active 2,3-benzoxazines
AU454743B2 (en) New pharmaceutically active 1, 4 dihydropyridines
CA727607A (en) 4-ALKYL AND 4-ARALKYL-ANDROSTAN 3,17.beta.-DIOL, THE .DELTA.4 DERIVATIVES AND THE 17.alpha.-LOWER ALKYL DERIVATIVES
AU5823469A (en) Anti-haemorrhoidally active preparations for rectal administration
AU2729267A (en) Therapeutic compositions based on n-(n', n'-dimethyl-dithio-carbamyl)-succinimide
AU4980869A (en) Pharmacologically active 2,3-benzoxazines
CA845198A (en) Fabrication d'alcools par oxydation d'hydrocarbures satures
ES351752A1 (en) Scilliglaucosidin-19-ol-alpha-l-rhamnoside